Erratum to: Bioequivalence and Tolerability Assessment of a Novel Intravenous Ciclosporin Lipid Emulsion Compared to Branded Ciclosporin in Cremophor^® EL

Erratum to: Clin Drug Investig DOI 10.1007/s40261-012-0029-x

A Published-Ahead-of-Print version of this article was made available online at http://adisonline.com/druginvestigation/toc/publishahead on 28 November 2012. An error was subsequently identified in that version of the article, and the following correction should be noted:

Section 4, paragraph 6, line 4, which previously read:

“Ciclosporin^® is currently being investigated as pharmacological therapy in patients undergoing intervention treatment after myocardial infarction (the CIRCUS Phase III study, “Cyclosporine and Prognosis in Acute Myocardial Infarction [MI] Patients”, clinicaltrials.gov identifier NCT01502774).”

Should read:

“CicloMulsion^® is currently being investigated as pharmacological therapy in patients undergoing intervention treatment after myocardial infarction (the CIRCUS Phase III study, “Cyclosporine and Prognosis in Acute Myocardial Infarction [MI] Patients”, clinicaltrials.gov identifier NCT01502774).”